Disc Medicine (IRON) Non Operating Income (2022 - 2026)
Disc Medicine's (IRON) quarterly Non Operating Income came in at $6.1 million in Q1 2026, up 1.52% year-on-year from $6.0 million in Q1 2025, and down 6.99% on a QoQ basis from $6.5 million in Q4 2025.
Disc Medicine (IRON) Non Operating Income (2022 - 2026) Analysis & Trends
Disc Medicine (IRON) has 5 years of Non Operating Income data on file, last reported at $6.1 million in Q1 2026.
- On a quarterly basis, Non Operating Income rose 1.52% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $24.3 million, a 9.51% increase from a year earlier, with the FY2025 full-year figure at $24.2 million, up 16.8% from the prior year.
- Non Operating Income for Q1 2026 stood at $6.1 million, down from $6.5 million in the prior quarter.
- Over the last five years, Non Operating Income for IRON reached as high as $6.5 million in Q4 2025 and fell as low as -$5.7 million in Q3 2022.
- Historically, Non Operating Income has averaged $3.9 million across 5 years, with a median of $4.9 million in 2023.
- On a YoY basis, Non Operating Income climbed as much as 2112.15% in 2023 and fell as far as 42.3% in 2023.
- Year by year, Non Operating Income stood at $3.8 million in 2022, then jumped by 63.28% to $6.2 million in 2023, then retreated by 14.56% to $5.3 million in 2024, then climbed by 23.88% to $6.5 million in 2025, then fell by 6.99% to $6.1 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $6.1 million in Q1 2026, $6.5 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 6.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.07 Mn |
| Dec 31, 2025 | 6.53 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 5.98 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 6.37 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 6.17 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 2.37 Mn |
| Dec 31, 2022 | 3.78 Mn |
| Sep 30, 2022 | -5.67 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 107,000.00 |